Researcher Profile

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 117 (Search time: 0.004 seconds).

No. Year Title Type
117 2024

2024Article

Deficiency of thioredoxin-interacting protein (TXNIP) results in age-related thrombocytopenia due to megakaryocyte oxidative stressJournal of Thrombosis and Haemostasis, vol. 22, no. 3, pp. 834-850Eunju Shin; C Park; Taeho Park; Hyunmin Chung; H Hwang; Sung Ho Bak; Kyung-Sook ChungSuk Ran YoonTae-Don Kim; In Pyo Choi, et al.
Article
116 2023

2023Report

항암 CAR-면역세포치료제의 고도화 플랫폼 개발 = Platform development of optimized CAR-immune cell therapy연구책임자 : 김태돈 / 주관부처 : 과학기술정보통신부김태돈이수연; 오세찬; 김석민; 장인환; 서지연; 김지현
Report
115 2023

2023Report

난치성 간암 치료를 위한 항 GPC-3 CAR-NK 치료제 개발 = Development of anti-GPC-3 CAR-NK cells for the treatment of intractable liver cancer연구책임자 : 김태돈 / 주관부처 : 과학기술정보통신부김태돈이수연; 조선아
Report
114 2023

2023Report

난치성 T세포 혈액암종을 타겟하는 CD5 CAR-NK의 선도치료제 도출 및 최적화 = Development and optimization of lead CD5 CAR-NK therapy for T cell malignancies연구책임자 : 김태돈 / 주관부처 : 보건복지부김태돈이수연
Report
113 2023

2023Patent

항-코티닌 키메릭 항원 수용체를 발현하는 자연살해 세포US16/503,984 (2019.07.05) / 11,707,486 (2023.07.25)최인표; 이수연이수의김태돈
Patent
112 2023

2023Patent

항-코티닌 키메릭 항원 수용체를 발현하는 자연살해 세포CN201880006118.1 (2019.07.05) / ZL 201880006118.1 (2023.07.18)최인표; 이수연이수의김태돈
Patent
111 2023

2023Patent

신규한 항-PD-L1 키메릭 항원 수용체 및 이를 발현하는 면역세포KR10-2022-0111672 (2022.09.02) / 10-2534281-0000 (2023.05.15)김태돈이수연
Patent
110 2023

2023Patent

단백질 발현용 mRNA 구조체 및 이의 용도KR10-2020-0161549 (2020.11.26) / 10-2490457-0000 (2023.01.16)최인표; 강희영; 김태돈
Patent
109 2023

2023Article

A modifiable universal cotinine-chimeric antigen system of NK cells with multiple targetsFrontiers in Immunology, vol. 13, pp. 1089369-1089369Hee Young Kang; Soo Yun Lee; H M Kim; Su Ui Lee; H Lee; M Y Cho; Se-Chan Oh; Seok-Min Kim; H S Park; E H Han, et al.
Article
108 2023

2023Article

NgR1 is an NK cell inhibitory receptor that destabilizes the immunological synapseNature Immunology, vol. 24, no. 3, pp. 463-473Se-Chan Oh; S E Kim; In Hwan Jang; Seok-Min Kim; Soo Yun Lee; Sunyoung Lee; In-Sun Chu; Suk Ran YoonHaiyoung Jung; In Pyo Choi, et al.
Article
107 2023

2023Article

FTO negatively regulates the cytotoxic activity of natural killer cellsEMBO Reports, vol. 24, no. 4, pp. e55681-e55681Seok-Min Kim; Se-Chan Oh; Sun-Young Lee; Ling-Zu Kong; J H Lee; Tae-Don Kim
Article
106 2023

2023Research Project

난치성 T세포 혈액암종을 타겟하는 CD5 CAR-NK의 선도치료제 도출 및 최적화연구책임자 : 김태돈 / 사업기간 : 2023.01.01 ~ 2023.08.31
Research Project
105 2023

2023Research Project

신규 합성기술 기반 고효율 mRNA 백신 플랫폼 개발 = Development of mRNA vaccine platforms using novel synthetic molecular design연구책임자 : 김태돈 / 사업기간 : 2023.01.01 ~ 2023.12.31
Research Project
104 2023

2023Article

Verproside, the most active ingredient in YPL-001 isolated from Pseudolysimachion rotundum var. subintegrum, decreases inflammatory response by inhibiting PKCδ activation in human lung epithelial cellsInternational Journal of Molecular Sciences, vol. 24, no. 8, pp. 7229-7229Eun Sol Oh; Hyung Won RyuMun-Ock KimJae-Won Lee; Yu Na Song; Ji-Yoon Park; Doo-Young Kim; H Ro; Jinhyuk LeeTae-Don Kim, et al.
Article
103 2023

2023Research Project

항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2023.01.01 ~ 2023.12.31
Research Project
102 2023

2023Research Project

항암 CAR-면역세포치료제의 고도화 플랫폼 개발 = Platform development of optimized CAR-immune cell therapy연구책임자 : 김태돈 / 사업기간 : 2023.05.01 ~ 2023.12.31
Research Project
101 2023

2023Article

NK cells encapsulated in micro/macropore-forming hydrogels via 3D bioprinting for tumor immunotherapyBiomaterials Research, vol. 27, pp. 60-60D Kim; S Jo; D Lee; Seok-Min Kim; J M Seok; S J Yeo; J H Lee; J J Lee; K Lee; Tae-Don Kim, et al.
Article
100 2023

2023Research Project

헬스케어 산업소재 적용 맞춤형 세포주 개발 및 제작 서비스 플랫폼 = Production service platform and custom cell line development applied to healthcare industry materials연구책임자 : 박영호 / 사업기간 : 2023.01.01 ~ 2023.12.31
Research Project
99 2023

2023Article

Understanding nucleic acid sensing and its therapeutic applicationsExperimental and Molecular Medicine, vol. 55, no. 11, pp. 2320-2331Ling-Zu Kong; Seok-Min Kim; Chunli Wang; Soo Yun Lee; Se-Chan Oh; Sunyoung Lee; Seona Jo; Tae-Don Kim
Article
98 2023

2023Article

Breakthroughs in cancer immunotherapy: an overview of T cell, NK cell, Mφ, and DC-based treatmentsInternational Journal of Molecular Sciences, vol. 24, no. 24, pp. 17634-17634Sunyoung Lee; Tae-Don Kim
Article
1 2 3 4 5 6